J Endocr Surg.  2021 Sep;21(3):61-69. 10.16956/jes.2021.21.3.61.

Betamethasone to Prevent Symptomatic Hypocalcaemia and Other Complications after Total Thyroidectomy: a Case-control Study

Affiliations
  • 1Department of Surgery, Hospital “P. Colombo”, Velletri, Italy
  • 2Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Terracina, Latina, Italy
  • 3Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University of Rome, Rome, Italy
  • 4Department of Surgery, “Pietro Valdoni”, Sapienza University of Rome, Rome, Italy

Abstract

Purpose
The study aims to determine whether postoperative infusion of betamethasone reduces the risk of symptomatic hypocalcaemia (SHC) and other complications after total thyroidectomy.
Methods
We compared a group of patients receiving betamethasone (beta group) postoperatively to a group without any perioperative glucocorticoid infusion (no beta group). Plasma levels of parathyroid hormone, total calcium, and C-reactive protein (CRP) were measured pre- and postoperatively. Complications were recorded within a 30-day follow-up. Postoperative SHC was the primary outcome.
Results
In the beta group and the no beta group, 54 patients and 47 patients were included, respectively. In the beta group, the incidence of SHC (4 pts vs. 14 pts in the no beta group; P=0.003) was reduced. In the beta group, serum calcium levels were higher on postoperative day 1 (8.6 mg/dL vs. 8.2 mg/dL in the no beta group; P=0.001) and day 2 (8.7 mg/dL vs. 8.1 mg/dL in the no beta group; P<0.000). In the beta group, serum C-reactive protein levels were lower postoperatively. In a univariate analysis, American Society of Anaesthesiology score > I (odds ratio [OR], 0.19; P=0.002), no betamethasone treatment (OR, 0.19; P=0.006), and parathyroid glands remaining in situ (PGRIS) score <3 (OR, 6.00; P=0.005) were related to postoperative SHC; in a multivariate analysis, betamethasone treatment (OR, 0.09; P=0.007) and PGRIS score <3 (OR, 8.41; P=0.045) were related to postoperative SHC. No difference was observed in postoperative complications.
Conclusion
Postoperative use of betamethasone reduces the incidence of SHC after thyroid surgery without affecting other complications.

Keyword

Thyroidectomy; Complications; Hypocalcemia; Betamethasone
Full Text Links
  • JES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr